Drug developer ADARx seeks $1.74 billion valuation in US IPO

Reported by Yahoo Finance · Published 22 Sep 2026, 1:00 AM MYT (2 hr ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

Singing lemurs may use a soprano-like trick to project songs 5 min ago California governor signs broad data center oversight bill package 20 min ago AI could boost LatAm, Caribbean economy 5.1% but wages may fall, IDB says 43 min ago Paramount settles lawsuit with US states, helping clear way for $110bn merger with Warner Bros 1 hr ago Behind the Ticker: Crossmark's Values-Based ETFs 1 hr ago The Stock Market Is Flashing a Rare Warning Signal. Here's How History Says Investors Should Prepare. 1 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Drug developer ADARx seeks $1.74 billion valuation in US IPO

Summary

More in Markets

Behind the Ticker: Crossmark's Values-Based ETFs

The Stock Market Is Flashing a Rare Warning Signal. Here's How History Says Investors Should Prepare.

Microsoft and Anthropic dominate Nscale's $103B IPO contract backlog

Not Nvidia. Not Micron. Meet the AI Infrastructure Stock That Could Triple in Just 3 Years

Arm’s Shift From Royalties to Silicon Manufacturing Could Reshape Chip Economics

Halliburton Signs Deals to Expand Venezuela Energy Presence